Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 2

2(40.0%)

5Total

N/A(3)

Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06283979Phase 2Recruiting

A Randomized Controlled Phase II Trial of STIMULAN VG vs Standard of Care (SoC) for the Treatment of Osteomyelitis Associated With Stage IV Pressure Ulcers.

Role: lead

NCT05706909Active Not Recruiting

The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head

Role: collaborator

NCT07270380Not ApplicableNot Yet Recruiting

Antibiotic Device for Osteomyelitis of the Extremities Pivotal Trial - Genex With Gentamicin.

Role: lead

NCT05539963Phase 2Active Not Recruiting

A Feasibility Trial to Investigate the Safety and Between-group Effect Size of STIMULAN VG and Standard of Care (SoC) in Participants With Diabetic Foot Osteomyelitis

Role: lead

NCT06808568Unknown

Expanded Access Program (EAP) STIMULAN VG

Role: lead

NCT03875963Not ApplicableTerminated

Antibiotic Loaded Calcium Sulfate RCT

Role: collaborator

NCT02456194Not ApplicableCompleted

Management of Traumatic Bone Defects in Tibial Plateau Fractures With Antibiotic-Impregnated Biodegradable Calcium Sulfate Beads: A Prospective Clinical Trial

Role: collaborator

All 7 trials loaded